Dec21Mon
IABCN Founder & Chairman Emeritus, Bill McLaughlin, participated in the 2016 Global Irish Economic Forum last month, the fourth such forum.
While previous Forums concentrated on recovery from the financial crisis, and rebuilding Ireland’s reputation internationally, this year the overarching theme was on sustaining and strengthening our robust economic growth into the future, with a particular focus on opportunities in high-potential sectors including financial services, research and innovation and international education. It also focused on fostering entrepreneurship and supporting indigenous businesses to scale up, increase exports and create jobs at home. To learn more, please click HERE.
To read the November Global Irish Newsletter, please click HERE.
Bill McLaughlin, IABCN Founder, with Tom Arnold, Director General, Institute of International and European Affairs
Dec09Wed
ICON Accelerates Site Activation Timelines by up to 25%
Cycle times reduced through process improvement and implementation of industry leading technology
Dublin, Ireland, 9 December, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has accelerated its study start-up timelines globally and has achieved a reduction of mean start-up cycle times by up to 25%.
Dec09Wed
Bill McLaughlin and Patricia Harty at the 30th Annual Irish Business 100
ICON Acquires PMG Research Inc.
Acquisition enhances ICON’s site and patient engagement capabilities
Dublin, Ireland, 7th December, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PMG Research, Inc., an integrated network of clinical research sites operating from 12 metropolitan areas throughout the US. The acquisition will enhance ICON’s ability to access and engage with investigator sites and patients, helping customers to reduce the overall time and cost associated with drug development.
Avoca set for major Irish and UK expansion
Aramark, which has agreed to buy the luxury cafe and retail chain for €60m, will consider bringing it to US.
Avoca’s new owner Aramark is to finance an aggressive expansion of the brand in Ireland before taking it to the UK. The multinational caterer, which bought the cafe chain from the Pratt family for about €60 million, may also open outlets in the US.
Over the next two years, Avoca is to add five or six new cafe and retail stores to its existing network of 11 in Ireland, according to Aramark Ireland’s chief executive, Donal O’Brien.
Mr O’Brien mentioned Cork, Galway, Limerick and Waterford as potential locations. Avoca outlets are mostly clustered around Dublin and Wicklow. It also operates from Kerry, Belfast and has a retail-only store in Connemara.
Read more at irishtimes.com/business
